Discover Insights on Our Deep Tech Commercialisation Blog

Many deep-tech and biotech founders believe that strong science will naturally attract funding and commercial success. Unfortunately, this is rarely the case. In reality, investors are not only evaluating the quality of the technology. They are assessing whether the innovation can become a scalable, sustainable business. A scientifically impressive product may still struggle commercially because of: high manufacturing costs, regulatory complexity, unclear market demand, limit